Advertisement.

LXEO Projected Dividend Yield

Lexeo Therapeutics Inc ( NASDAQ : LXEO )

Lexeo Therapeutics is a clinical stage genetic medicine company engaged in transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Co.'s primary cardiovascular product candidate, LX2006, for the treatment of patients with Friedreich's ataxia cardiomyopathy. Co.'s second cardiovascular product candidate, LX2020, for the treatment of arrhythmogenic cardiomyopathy. Co.'s main Alzheimer's disease product candidate, LX1001, for the treatment of APOE4 homozygous patients with Alzheimer's disease.

20 YEAR PERFORMANCE RESULTS

LXEO Dividend History Detail
LXEO Dividend News
LXEO Competitors News

# of Shares: 0

Closing Price: 6.88

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000